BIG 2-04

Share This Post

Selective Use of Postoperative Radiotherapy AftEr Mastectomy: adjuvant chest wall irradiation for ‘intermediate risk’ breast cancer following mastectomy.

Funding: UK Medical Research Council, EORTC, Cancer Australia, William and Elizabeth Davies Charitable Trust, Peter Chan Jee Yat Foundation, Yeung Ying Yin and May Yeung Foundation

More To Explore


Panacea BIG 4-13 PANACEA stands for anti-PD-1 monoclonAl aNtibody in AdvanCed, trastuzumab-resistant, HER2-positive breAst cancer. A phase Ib/II trial evaluating the efficacy of pembrolizumab and trastuzumab

Read More


DECRESCENDO BIG 19-02 De-Escalation of adjuvant ChemotheRapy in HER2-positive, EStrogen reCEptor-negative, Node-negative early breast cancer patients who achieved pathological complete response after neoadjuvant chemotherapy and Dual HER2 blOckade Share

Read More